1. Home
  2. NVCR vs NEXT Comparison

NVCR vs NEXT Comparison

Compare NVCR & NEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • NEXT
  • Stock Information
  • Founded
  • NVCR 2000
  • NEXT 2010
  • Country
  • NVCR Switzerland
  • NEXT United States
  • Employees
  • NVCR N/A
  • NEXT N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • NEXT Oil & Gas Production
  • Sector
  • NVCR Health Care
  • NEXT Energy
  • Exchange
  • NVCR Nasdaq
  • NEXT Nasdaq
  • Market Cap
  • NVCR 1.9B
  • NEXT 2.0B
  • IPO Year
  • NVCR 2015
  • NEXT N/A
  • Fundamental
  • Price
  • NVCR $16.69
  • NEXT $8.44
  • Analyst Decision
  • NVCR Buy
  • NEXT
  • Analyst Count
  • NVCR 6
  • NEXT 0
  • Target Price
  • NVCR $32.83
  • NEXT N/A
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • NEXT 1.8M
  • Earning Date
  • NVCR 07-24-2025
  • NEXT 08-13-2025
  • Dividend Yield
  • NVCR N/A
  • NEXT N/A
  • EPS Growth
  • NVCR N/A
  • NEXT N/A
  • EPS
  • NVCR N/A
  • NEXT N/A
  • Revenue
  • NVCR $621,711,000.00
  • NEXT N/A
  • Revenue This Year
  • NVCR $5.56
  • NEXT N/A
  • Revenue Next Year
  • NVCR $9.19
  • NEXT N/A
  • P/E Ratio
  • NVCR N/A
  • NEXT N/A
  • Revenue Growth
  • NVCR 18.27
  • NEXT N/A
  • 52 Week Low
  • NVCR $14.17
  • NEXT $4.27
  • 52 Week High
  • NVCR $34.13
  • NEXT $9.71
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.44
  • NEXT 59.25
  • Support Level
  • NVCR $17.20
  • NEXT $8.16
  • Resistance Level
  • NVCR $18.02
  • NEXT $8.74
  • Average True Range (ATR)
  • NVCR 1.04
  • NEXT 0.36
  • MACD
  • NVCR -0.09
  • NEXT 0.01
  • Stochastic Oscillator
  • NVCR 15.51
  • NEXT 66.29

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas and sale of LNG and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

Share on Social Networks: